Clinical Trial With a Depigmented, Polymerized Mite Mixture Extract at Maximum Concentrations
2024

Safety and Efficacy of Allergen Immunotherapy with Mite Extracts

Sample size: 40 publication 10 minutes Evidence: moderate

Author Information

Author(s): Carmen Vidal, Laura Romero, Sarah Lopez‐Freire, Francisco Carballada‐Gonzalez, José Carlos Garcia‐Robaina, Teresa Gonzalez‐Fernandez, Paula Mendez‐Brea, Eva Nieto, Mónica Ruiz‐Garcia

Primary Institution: Complejo Hospitalario de Santiago

Hypothesis

The study aims to assess the safety and tolerability of subcutaneous immunotherapy with mixtures of mite allergen extracts at maximum concentrations in patients with allergic rhinitis and controlled asthma.

Conclusion

The study found that subcutaneous immunotherapy with mite allergen extracts at maximum concentrations has a favorable safety profile and effectively reduces symptoms of allergic rhinitis and asthma.

Supporting Evidence

  • 40 patients were recruited for the study, with 97.5% experiencing at least one adverse event.
  • None of the patients experienced immediate or delayed systemic reactions of grade ≥2.
  • The median combined symptom and rescue medication score decreased significantly over the study period.

Takeaway

This study tested a treatment for allergies caused by dust mites and found it to be safe and helpful for people with sneezing and breathing problems.

Methodology

An open-label, noncontrolled, nonrandomised, phase IIb clinical trial was conducted in three hospitals in Spain, where patients received subcutaneous immunotherapy with two different mite allergen mixtures.

Potential Biases

Potential bias due to the open-label design and lack of randomization.

Limitations

The study lacked a control group and had a small sample size, which may limit the generalizability of the results.

Participant Demographics

Participants were adults aged 18 to 70, with a majority being female (65%) and having moderate-to-severe allergic rhinitis or rhinoconjunctivitis.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/iid3.70090

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication